Mean platelet volume and cardiovascular outcomes in acute myocardial infarction

Mangalachulli Pottammal Ranjith1, Rajendran DivyaRaj2, Dolly Mathew3

  • 1Department of Cardiology , Kannur Medical College , Anjarakandy, Kerala , India.

Heart Asia
|June 22, 2016
PubMed
Abstract

Insights

Elevated mean platelet volume (MPV) in patients with myocardial infarction (MI) is linked to worse outcomes. This finding suggests larger platelets may indicate higher cardiovascular risk in MI patients.

Area of Science:

  • Cardiology
  • Hematology
  • Clinical Research

Background:

  • High mean platelet volume (MPV) is potentially linked to adverse outcomes in myocardial infarction (MI) patients.
  • Platelet characteristics, including MPV, play a role in cardiovascular disease pathogenesis.
  • Understanding MPV's prognostic value can aid in risk stratification for MI patients.

Purpose of the Study:

  • To investigate the association between MPV levels and the risk of death and adverse cardiovascular outcomes in patients following MI.
  • To determine if baseline MPV is a predictor of long-term cardiovascular events in MI survivors.

Main Methods:

  • A cohort of 1206 consecutive MI patients was studied.
  • Mean platelet volume (MPV) was measured at hospital admission and at the third month post-admission.
  • Patients were followed for one year to assess a composite outcome including cardiovascular death, stroke, recurrent MI, and cardiac failure, categorized by baseline MPV tertiles.

Main Results:

  • Patients in the highest MPV tertile exhibited a significantly higher risk of the primary composite outcome (adjusted OR=2.31) and total mortality (adjusted OR=2.62) compared to those in the lowest tertile.
  • The study included 1206 MI patients (77.4% men, mean age 56 years).
  • No significant changes in MPV were observed between admission and the third month (9.15 vs. 9.19).

Conclusions:

  • Elevated MPV is associated with worse clinical outcomes in patients diagnosed with acute myocardial infarction.
  • The presence of inherently large platelets, indicated by elevated MPV, may contribute to adverse cardiovascular events post-MI.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.4K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.5K
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
5.5K